DEXCOM INC

DXCM

DEXCOM INC

DXCM

Insider Sentiment (TTM):

Last Purchase:2025-11-10Last Sale:2026-06-15Shares Purchased (TTM):18,200Shares Sold (TTM):59,317

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:346,187,094Shares Outstanding:385,100,000Institutional Ownership Pct.:89.90%

Earnings Market Reaction:

Filing Date:2026-07-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1,105	1,118	918	1,836	1,159	905	606	621	939	851	566	644
Accounts Receivable Net Current	1,258	1,089	1,216	1,110	1,349	1,155	1,006	1,002	945	979	974	786
Inventory Net	726	694	629	604	571	538	543	586	570	589	560	499
Prepaid Expense And Other Assets Current	156	134	189	184	181	159	174	182	212	156	168	174
Assets Current	4,087	4,332	4,033	5,220	5,030	4,554	4,301	4,263	4,848	4,621	4,426	4,698
Property Plant And Equipment And Finance Lease Rig…	1,577	1,560	1,560	1,471	1,457	1,365	1,340	1,319	1,183	1,109	1,113	1,079
Operating Lease Right Of Use Asset	88	73	77	54	56	59	63	68	71	68	71	73
Goodwill	24	24	24	24	24	23	23	24	23	23	25	25
Intangible Assets Net Excluding Goodwill	102	63	71	79	87	95	103	106	115	123	135	145
Deferred Income Tax Assets Net	304	296	296	376	496	487	481	487	476	461	419	501
Other Assets Noncurrent	274	286	279	277	176	169	173	88	83	78	75	74
Assets	6,455	6,633	6,340	7,500	7,327	6,752	6,485	6,354	6,799	6,482	6,265	6,596
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Other Accrued Liabilities Cur…	2,192	2,074	1,944	1,932	1,944	1,691	1,585	1,593	1,570	1,447	1,346	1,373
Employee Related Liabilities Current	136	122	169	170	129	111	112	106	116	111	171	151
Convertible Notes Payable Current	-	-	0	1,207	1,206	1,205	1,204	-	-	-	0	124
Operating Lease Liability Current	21	21	22	24	23	23	23	22	22	21	21	21
Contract With Customer Liability Current	-	-	-	3	6	8	8	14	15	16	18	9
Other Liabilities Current	9	8	8	-	-	-	8	-	-	-	-	-
Liabilities Current	2,358	2,224	2,143	3,336	3,309	3,037	2,932	1,735	1,722	1,594	1,556	1,679
Convertible Long Term Notes Payable	1,243	1,242	1,241	1,240	1,239	1,238	1,237	2,440	2,438	2,436	2,434	2,432
Operating Lease Liability Noncurrent	83	69	73	51	55	60	65	71	77	76	80	83
Other Liabilities Noncurrent	151	142	137	147	152	150	148	130	128	129	126	134
Liabilities	3,834	3,676	3,594	4,774	4,754	4,485	4,382	4,375	4,365	4,235	4,196	4,328
Stockholders Equity
Preferred Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	2,377	2,338	2,282	2,247	2,188	2,142	2,094	2,051	1,992	2,511	3,515	3,618
Accumulated Other Comprehensive Income Loss Net Of…	90	106	115	82	84	2	-8	63	-38	-37	-17	-36
Retained Earnings Accumulated Deficit	2,883	2,633	2,434	2,167	1,883	1,703	1,598	1,446	1,311	1,168	1,021	765
Treasury Stock Common Value	-2,728	-2,121	-2,085	-1,769	-1,581	-1,581	-1,581	-1,581	-832	-1,395	-2,451	-2,080
Stockholders Equity	2,621	2,957	2,746	2,726	2,573	2,267	2,103	1,979	2,434	2,247	2,069	2,268
Liabilities And Stockholders Equity	6,455	6,633	6,340	7,500	7,327	6,752	6,485	6,354	6,799	6,482	6,265	6,596
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	800	800	800	800	800	800	800	800	800	800	800	800
Common Stock Shares Issued	412	412	411	411	410	410	409	409	409	409	407	406
Shares Outstanding	377	386	385	390	392	392	391	391	401	396	385	386
Treasury Stock Common Shares	35	26	26	21	18	18	18	18	8	12	22	19

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	21.07%	21.70%	28.72%	-	-	-	-	-	-	-	-	-
2025	20.28%	13.86%	19.40%	-7.64%	-24.26%	-25.22%	-11.69%	-3.14%	1.96%	4.64%	-4.39%	-5.73%
2024	-4.82%	-15.98%	-17.35%	-30.78%	-35.55%	-35.83%	1.38%	3.13%	3.89%	-21.92%	-26.94%	-6.47%
2023	-	-	-	-	-	-	29.45%	51.18%	54.15%	-4.18%	9.17%	-2.13%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.73	1.95	1.88	1.56	1.52	1.50	1.47	2.46	2.82	2.90	2.84	2.80
Quick Ratio	1.36	1.58	1.50	1.33	1.29	1.27	1.22	2.01	2.36	2.43	2.38	2.40
Working Capital	1.73B	2.11B	1.89B	1.88B	1.72B	1.52B	1.37B	2.53B	3.13B	3.03B	2.87B	3.02B
Leverage & Debt
Debt to Equity	1.46	1.24	1.31	1.75	1.85	1.98	2.08	2.21	1.79	1.89	2.03	1.91
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	110.44	56.92	33.30
Debt Ratio	0.59	0.55	0.57	0.64	0.65	0.66	0.68	0.69	0.64	0.65	0.67	0.66
Efficiency & Turnover
Asset Turnover TTM	0.72	0.72	0.73	0.65	0.61	0.63	0.63	0.61	0.58	0.63	0.62	0.59
Days Sales Outstanding TTM	95.73	84.99	86.98	85.34	97.34	93.88	89.58	82.51	78.65	77.54	85.01	72.39
Receivables Turnover TTM	3.81	4.29	4.20	4.28	3.75	3.89	4.07	4.42	4.64	4.71	4.29	5.04
Per Share Metrics
Diluted EPS TTM	2.56	2.36	2.06	1.77	1.40	1.31	1.40	1.66	1.60	1.53	1.27	0.88
Free Cash Flow Per Share TTM	3.68	3.71	2.76	2.72	1.46	1.47	1.60	1.36	1.67	1.50	1.33	1.29
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	62.47%	61.50%	60.10%	59.01%	58.77%	59.43%	60.46%	61.68%	62.74%	62.82%	63.19%	63.87%
Operating Profit Margin TTM	22.92%	21.45%	19.56%	17.22%	15.98%	15.25%	14.88%	15.88%	17.32%	17.14%	16.50%	14.88%
Net Profit Margin TTM	20.12%	19.31%	17.94%	15.96%	13.29%	12.90%	14.29%	17.22%	16.95%	16.82%	14.95%	11.08%
Growth Metrics
Net Revenue Growth (1Y)	15.54%	16.15%	15.60%	14.21%	9.30%	9.11%	11.34%	16.19%	23.05%	25.78%	24.49%	21.85%
Net Income Growth (1Y)	74.93%	73.84%	45.14%	5.86%	-14.30%	-16.28%	6.41%	80.58%	86.55%	118.56%	58.70%	54.44%
EPS Growth (1Y)	79.46%	76.55%	46.41%	6.70%	-12.75%	-16.48%	4.35%	77.10%	80.70%	116.60%	60.10%	55.72%
Valuation Metrics
P/E TTM	25.75	25.99	30.97	36.52	59.89	49.90	53.12	38.82	67.87	84.66	88.46	95.68
P/B TTM	9.82	8.18	9.43	9.65	13.30	11.78	14.56	13.35	18.59	24.09	23.16	15.90
P/S TTM	5.18	5.02	5.56	5.83	7.96	6.44	7.59	6.68	11.50	14.24	13.22	10.60
Market Cap	25.74B	24.18B	25.90B	26.32B	34.23B	26.71B	30.61B	26.43B	45.26B	54.12B	47.90B	36.07B
Enterprise Value	25.88B	24.31B	26.22B	26.93B	35.51B	28.25B	32.44B	28.24B	46.76B	55.70B	49.77B	37.98B
Calculated Values
Free Cash Flow TTM	1.41B	1.43B	1.08B	1.06B	570.80M	575.20M	630.70M	535.00M	665.50M	583.50M	511.90M	499.80M
Net Debt	137.60M	123.40M	321.80M	609.90M	1.28B	1.54B	1.83B	1.82B	1.50B	1.58B	1.87B	1.91B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Sale

Owner: Foletta, Mark G

Title: -

Shares: 4,000

Price/Share: $74.46

Value: $297,840.00

Shares Owned: 52,852

Relationship: Director

Ownership: Indirect

2026-06-15Sale

Owner: Brown, Michael Jon

Title: EVP Chief Legal Compliance Off

Shares: 1,700

Price/Share: $75.55

Value: $128,435.00

Shares Owned: 106,353

Relationship: Officer

Ownership: Direct

2026-06-04Sale

Owner: Coleman, Jon

Title: EVP, Chief Commercial Officer

Shares: 4,911

Price/Share: $74.13

Value: $364,052.43

Shares Owned: 95,450

Relationship: Officer

Ownership: Direct

2026-05-21Sale

Owner: Sayer, Kevin R

Title: Executive Chair

Shares: 26,759

Price/Share: $72.00

Value: $1,926,648.00

Shares Owned: 382,482

Relationship: Director,Officer

Ownership: Direct

2026-05-15Sale

Owner: Brown, Michael Jon

Title: EVP, Chief Legal Officer

Shares: 1,700

Price/Share: $59.91

Value: $101,847.00

Shares Owned: 109,504

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Foletta, Mark G	Director	-	Indirect	Sale	4,000	74.46	$297,840.00	52,852	4
2026-06-15	Brown, Michael Jon	Officer	EVP Chief Legal Compliance Off	Direct	Sale	1,700	75.55	$128,435.00	106,353	4
2026-06-04	Coleman, Jon	Officer	EVP, Chief Commercial Officer	Direct	Sale	4,911	74.13	$364,052.43	95,450	4
2026-05-21	Sayer, Kevin R	Director,Officer	Executive Chair	Direct	Sale	26,759	72.00	$1,926,648.00	382,482	4
2026-05-15	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	1,700	59.91	$101,847.00	109,504	4
2026-05-12	Heller, Bridgette P	Director	-	Direct	Sale	1,012	60.01	$60,730.12	25,007	4
2026-04-15	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	1,700	63.04	$107,168.00	111,204	4
2026-03-16	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	1,700	64.85	$110,245.00	112,904	4
2026-02-12	Heller, Bridgette P	Director	-	Direct	Sale	1,012	68.01	$68,826.12	26,019	4
2025-11-14	Collins, Richard Alexande…	Director	-	Indirect	Sale	2,906	59.05	$171,599.30	35,088	4
2025-11-12	Heller, Bridgette P	Director	-	Direct	Sale	1,012	58.07	$58,766.84	27,031	4
2025-11-10	Leach, Jacob Steven	Officer	President & COO	Direct	Purchase	18,200	55.20	$1,004,640.00	331,697	4
2025-11-10	Collins, Richard Alexande…	Director	-	Indirect	Sale	3,948	55.17	$217,811.16	37,994	4
2025-09-05	Malady, Kyle	Director	-	Direct	Sale	667	80.86	$53,933.62	22,667	4
2025-09-04	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	1,466	80.00	$117,280.00	105,223	4
2025-09-02	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	4,824	74.17	$357,796.08	118,657	4
2025-08-15	Foletta, Mark G	Director	-	Indirect	Sale	2,750	81.28	$223,520.00	51,121	4
2025-08-15	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	500	80.29	$40,145.00	94,102	4
2025-07-28	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	1,466	88.99	$130,459.34	106,689	4
2025-07-15	Foletta, Mark G	Director	-	Indirect	Sale	2,750	85.60	$235,400.00	53,871	4
2025-07-15	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	500	86.03	$43,015.00	94,602	4
2025-06-26	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	1,466	85.06	$124,697.96	108,155	4
2025-06-16	Augustinos, Nicholas	Director	-	Indirect	Sale	3,672	82.80	$304,041.60	33,411	4
2025-06-16	Foletta, Mark G	Director	-	Indirect	Sale	2,750	83.13	$228,607.50	56,621	4
2025-06-16	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	500	82.80	$41,400.00	95,102	4
2025-05-27	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	6,184	85.11	$526,320.24	109,621	4
2025-05-23	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	10,000	84.28	$842,800.00	95,602	4
2025-03-17	Heller, Bridgette P	Director	-	Direct	Sale	352	70.33	$24,756.16	22,997	4
2025-03-12	Sayer, Kevin R	Director,Officer	Chairman, CEO & President	Direct	Sale	32,498	70.38	$2,287,209.24	372,029	4
2025-03-12	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	13,000	70.38	$914,940.00	105,602	4
2025-03-12	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	11,176	70.38	$786,566.88	115,805	4
2025-03-12	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	12,001	70.38	$844,630.38	123,481	4
2025-03-12	Leach, Jacob Steven	Officer	EVP, Chief Operating Officer	Direct	Sale	14,076	70.38	$990,668.88	313,497	4
2025-03-10	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	7,000	73.99	$517,930.00	135,482	4
2025-01-29	Leach, Jacob Steven	Officer	EVP, Chief Operating Officer	Direct	Sale	2,634	86.91	$228,920.94	268,644	4
2025-01-29	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	2,090	86.91	$181,641.90	83,526	4
2025-01-29	Sayer, Kevin R	Director,Officer	Chairman, CEO & President	Direct	Sale	33,359	86.91	$2,899,230.69	319,037	4
2025-01-29	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	2,093	86.91	$181,902.63	74,261	4
2025-01-29	Dolan, Matthew Vincent	Officer	EVP, Strategy & Corporate Dev	Direct	Sale	1,183	86.91	$102,814.53	42,044	4
2024-12-16	Leach, Jacob Steven	Officer	EVP, Chief Operating Officer	Direct	Sale	744	76.87	$57,191.28	264,171	4
2024-12-16	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	744	76.87	$57,191.28	80,030	4
2024-12-16	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	424	76.87	$32,592.88	70,768	4
2024-12-16	Heller, Bridgette P	Director	-	Direct	Sale	1,000	76.87	$76,870.00	23,349	4
2024-11-20	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	4,259	74.73	$318,275.07	71,192	4
2024-11-15	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	3,500	75.51	$264,285.00	80,774	4
2024-09-16	Heller, Bridgette P	Director	-	Direct	Sale	1,000	70.00	$70,000.00	24,349	4
2024-09-09	Sylvain, Jereme M	Officer	EVP, Chief Financal Officer	Direct	Sale	746	69.15	$51,585.90	84,274	4
2024-09-09	Stern, Sadie	Officer	EVP, Chief HR Officer	Direct	Sale	426	69.15	$29,457.90	75,451	4
2024-09-09	Leach, Jacob Steven	Officer	EVP, Chief Operating Officer	Direct	Sale	746	69.15	$51,585.90	264,915	4
2024-08-30	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	686	70.00	$48,020.00	65,636	4
2024-07-31	Brown, Michael Jon	Officer	EVP, Chief Legal Officer	Direct	Sale	652	69.55	$45,346.60	66,249	4
2024-06-28	Brown, Michael Jon	Officer	EVP Chief Legal Officer	Direct	Sale	659	114.29	$75,317.11	66,901	4
2024-06-18	Foletta, Mark G	Director	-	Indirect	Sale	3,306	117.00	$386,802.00	56,398	4
2024-06-14	Heller, Bridgette P	Director	-	Direct	Sale	1,000	113.55	$113,550.00	25,349	4
2024-06-10	Stern, Sadie	Officer	EVP Chief HR Officer	Direct	Sale	427	115.05	$49,126.35	75,877	4
2024-06-10	Sylvain, Jereme M	Officer	EVP Chief Financial Officer	Direct	Sale	745	115.05	$85,712.25	84,948	4
2024-06-10	Leach, Jacob Steven	Officer	EVP Chief Operating Officer	Direct	Sale	745	115.05	$85,712.25	265,577	4
2024-05-31	Brown, Michael Jon	Officer	EVP Chief Legal Officer	Direct	Sale	652	119.24	$77,744.48	67,560	4
2024-05-15	Dolan, Matthew Vincent	Officer	EVP Strategy and Corporate Dev	Direct	Sale	2,423	126.58	$306,703.34	40,075	4
2024-04-30	Brown, Michael Jon	Officer	EVP Chief Legal Officer	Direct	Sale	629	126.25	$79,411.25	68,212	4
2024-04-15	Dolan, Matthew Vincent	Officer	EVP Strategy and Corporate Dev	Direct	Sale	1,990	137.81	$274,241.90	42,377	4
2024-04-08	Sayer, Kevin R	Director,Officer	President CEO and Chairman	Direct	Sale	49,633	138.34	$6,866,229.22	283,893	4
2024-03-28	Brown, Michael Jon	Officer	EVP Chief Legal Officer	Direct	Sale	2,624	140.38	$368,357.12	68,682	4
2024-03-25	Stern, Sadie	Officer	EVP Chief Human Resources	Direct	Sale	4,137	140.00	$579,180.00	76,304	4
2024-03-15	Dolan, Matthew Vincent	Officer	EVP Strategy & Corp Dev	Direct	Sale	4,203	130.45	$548,281.35	44,367	4
2024-03-12	Stern, Sadie	Officer	EVP Chief Human Resources	Direct	Sale	20,321	132.67	$2,695,987.07	80,441	4
2024-03-12	Lawver, Teri L	Officer	EVP Chief Commercial Officer	Direct	Sale	4,764	134.41	$640,329.24	66,641	4
2024-03-12	Sayer, Kevin R	Director,Officer	President CEO and Chairman	Direct	Sale	81,007	133.19	$10,789,322.33	333,526	4
2024-03-12	Brown, Michael Jon	Officer	EVP Chief Legal Officer	Direct	Sale	8,799	134.41	$1,182,673.59	71,306	4
2024-03-12	Leach, Jacob Steven	Officer	EVP Chief Operating Officer	Direct	Sale	14,639	134.41	$1,967,627.99	273,913	4
2024-03-12	Sylvain, Jereme M	Officer	EVP Chief Financial Officer	Direct	Sale	11,661	134.41	$1,567,355.01	85,534	4
2024-03-12	Dolan, Matthew Vincent	Officer	EVP Strategy and Corporate	Direct	Sale	6,710	134.41	$901,891.10	48,570	4
2024-02-20	Sylvain, Jereme M	Officer	EVP Chief Financial Officer	Direct	Sale	3,363	116.73	$392,562.99	71,142	4
2024-01-16	Stern, Sadie	Officer	EVP Chief Human Resources	Direct	Sale	2,902	123.63	$358,774.26	79,051	4
2024-01-16	Altman, Steven R	Director	-	Indirect	Sale	1,568	122.60	$192,236.80	53,132	4
2024-01-16	Sylvain, Jereme M	Officer	EVP Chief Financial Officer	Direct	Sale	2,734	123.63	$338,004.42	74,505	4
2024-01-16	Leach, Jacob Steven	Officer	EVP Chief Operating Officer	Direct	Sale	3,978	123.63	$491,800.14	262,499	4
2024-01-16	Sayer, Kevin R	Director,Officer	President, CEO and Chairman	Direct	Sale	37,325	123.63	$4,614,489.75	362,841	4
2023-12-15	Augustinos, Nicholas	Director	-	Indirect	Sale	3,976	123.02	$489,127.52	34,040	4
2023-12-15	Altman, Steven R	Director	-	Indirect	Sale	2,000	122.77	$245,540.00	54,700	4
2023-12-12	Altman, Steven R	Director	-	Indirect	Sale	3,000	120.00	$360,000.00	56,700	4
2023-12-11	Stern, Sadie	Officer	EVP Chief Human Resources Offi	Direct	Sale	392	117.66	$46,122.72	76,008	4
2023-12-01	Brown, Michael Jon	Officer	EVP Chief Legal Officer	Direct	Sale	3,612	114.50	$413,574.00	58,394	4
2023-11-24	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	411	110.80	$45,538.80	124,775	4
2023-11-22	Stern, Sadie	Officer	EVP Chief Human Resources Offi	Direct	Sale	1,176	110.00	$129,360.00	76,400	4
2023-11-15	Altman, Steven R	Director	-	Indirect	Sale	1,000	101.26	$101,260.00	59,700	4
2023-11-09	Naganathan, Girish	Officer	EVP Chief Technology Officer	Direct	Sale	2,725	93.27	$254,160.75	47,725	4
2023-11-08	Regan, Barry J.	Officer	EVP Operations	Direct	Sale	2,019	95.22	$192,249.18	64,250	4
2023-10-23	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	411	85.75	$35,243.25	125,186	4
2023-10-16	Altman, Steven R	Director	-	Indirect	Sale	1,000	77.58	$77,580.00	60,700	4
2023-09-22	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	411	88.40	$36,332.40	125,597	4
2023-09-15	Altman, Steven R	Director	-	Indirect	Sale	1,000	101.50	$101,500.00	61,700	4
2023-09-12	Heller, Bridgette P	Director	-	Direct	Sale	600	106.56	$63,936.00	23,731	4
2023-09-01	Dolan, Matthew Vincent	Officer	SVP Corporate Strategy-Develop	Direct	Sale	56	102.32	$5,729.92	33,569	4
2023-08-23	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	411	107.03	$43,989.33	126,008	4
2023-08-22	Sylvain, Jereme M	Officer	EVP Chief Financial Officer	Direct	Sale	1,844	104.38	$192,476.72	72,867	4
2023-08-09	Stern, Sadie	Officer	EVP Chief Human Resources Offi	Direct	Sale	392	110.71	$43,398.32	81,682	4
2023-07-24	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	412	130.58	$53,798.96	126,419	4
2023-07-14	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	5,031	136.00	$684,216.00	126,831	4
2023-07-10	Stern, Sadie	Officer	EVP Chief Human Resources Offi	Direct	Sale	392	128.05	$50,195.60	82,074	4
2023-07-10	Regan, Barry J.	Officer	EVP Operations	Direct	Sale	1,989	128.05	$254,691.45	66,269	4
2023-06-23	Pacelli, Steven Robert	Officer	EVP Managing Director Dexcom V	Direct	Sale	412	125.92	$51,879.04	131,862	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

89.90%

Inst. Shares: 346,187,094

Shares Outstanding: 385,100,000

2025-12-31

89.63%

Inst. Shares: 349,754,856

Shares Outstanding: 390,200,000

2025-09-30

90.97%

Inst. Shares: 355,766,876

Shares Outstanding: 391,100,000

2025-06-30

89.63%

Inst. Shares: 351,440,692

Shares Outstanding: 392,100,000

2025-03-31

88.61%

Inst. Shares: 346,555,064

Shares Outstanding: 391,100,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	346,187,094	385,100,000	89.90%
2025-12-31	349,754,856	390,200,000	89.63%
2025-09-30	355,766,876	391,100,000	90.97%
2025-06-30	351,440,692	392,100,000	89.63%
2025-03-31	346,555,064	391,100,000	88.61%
2024-12-31	344,714,975	393,600,000	87.58%
2024-09-30	340,261,583	394,200,000	86.32%
2024-06-30	358,030,559	399,200,000	89.69%
2024-03-31	345,093,426	390,200,000	88.44%
2023-12-31	356,820,841	386,000,000	92.44%
2023-09-30	347,837,013	386,600,000	89.97%
2023-06-30	347,852,639	386,700,000	89.95%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

DEXCOM INC (DXCM) — SEC Financial Statements & Analysis

DEXCOM INC (DXCM) is a surgical & medical instruments & apparatus company, incorporated in DE. DEXCOM INC trades on Nasdaq as: DXCM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), DEXCOM INC reported a 15.54% year-over-year revenue growth, a Gross Profit Margin of 62.47% (TTM), a Debt-to-Equity ratio of 1.46x, a Price-to-Sales (P/S) ratio of 5.18x (TTM), a Price-to-Book (P/B) ratio of 9.82x (TTM), at a market cap of $25.74B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 15.54%
Gross Profit Margin TTM: 62.47%
Debt To Equity: 1.46x
P/S TTM: 5.18x
P/B TTM: 9.82x
Market Cap: $25.74B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is DEXCOM INC in?

DEXCOM INC (DXCM) operates in the Surgical & Medical Instruments & Apparatus industry.

What is DXCM's market cap?

DEXCOM INC (DXCM) has a market capitalization of $25.74B as of 2026-06-30.

What is DXCM's P/E ratio?

DEXCOM INC (DXCM)'s trailing twelve month P/E ratio is 25.75x as of 2026-06-30.

What exchange does DXCM trade on?

DEXCOM INC (DXCM) trades on the Nasdaq.

Where is DEXCOM INC incorporated?

DEXCOM INC is incorporated in DE.

DEXCOM INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

DEXCOM INC (DXCM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

DEXCOM INC (DXCM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.